Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Sales | 92,839 | 0 | 0 |
| Cost of Goods | 41,129 | N/A | N/A |
| Gross Profit | 51,710 | N/A | N/A |
| Operating Expenses | 38,180 | 0 | 0 |
| Operating Income | 13,659 | N/A | N/A |
| Interest Expense | 333 | 0 | 0 |
| Other Income | 1,104 | 0 | 0 |
| Pre-tax Income | 14,430 | 0 | 0 |
| Income Tax | -4,981 | N/A | N/A |
| Net Income Continuous | 19,411 | N/A | N/A |
| Net Income | $19,411 | $N/A | $N/A |
| EPS Basic Total Ops | 0.11 | N/A | N/A |
| EPS Basic Continuous Ops | 0.67 | N/A | N/A |
| EPS Diluted Total Ops | 0.10 | N/A | N/A |
| EPS Diluted Continuous Ops | 0.60 | N/A | N/A |
| EBITDA(a) | $14,262 | $N/A | $N/A |